Conference Abstract
 
Navigation
Conference Abstracts Index

Abstracts - 2006 London

Abstracts - 2005 Zurich

Abstracts - 2004 Berlin

Abstracts - 2003 Barcelona

Abstracts - 2002 Brussels

Abstracts - 2001 Tokyo

Abstracts - 2000 Marburg

       

P9.125 THE EFFECTOF 1 MG FINASTERIDE DAILY IN TREATMENT OF ANDROGENIC ALOPECIA IN WOMEN

Anita Tarajkowska-Olejnik. Lidia Rudnicka

Dept. of Dermatology, Central Oinical Hospital MSW I A. Warsaw,
Poland

Finasteride is a well established drug in treatment of androgenic alopecia in men. The issue of potential efficacy of finasteride in androgenic alopecia in women is still controversial. This controversy relates to the potential dose of finasteride which should be used, treatment duration and to the question whether finaseride is at all effective in women. We applied finasteride to 8 women with androgenic alopecia refractory to other methods of treatment 6 of these patients were postmenopausal women and 2 patients have undergone hysterectomy due to uterine myoma prior to the treatment All patients were otherwise healthy and laboratory findings were within normal range. In all patients a significant, diffuse decrease in hair density, especially in mid scalp areas was observed within the last 5 years before onset. The efficacy of treatment was evaluated, based on hair count in trichograms, comparison of photographic documentation, clinical evaluation and a patient satisfaction sheet. Our results show significant improvement in trichogram after 4 months of treatment. This improvement was accompanied by clinical improvement and growing patient satisfaction. No side effects were observed. These results indicate that in some cases finasteride at the dose of 1 mg per day might be a useful therapeutic alternative in some female patients with androgenic alopecia.